Chinese Research Group of Gallbladder Cancer (CRGGC)

June 29, 2021 updated by: Yingbin Liu, MD, PhD, FACS, Shanghai Jiao Tong University School of Medicine
The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The objectives of the CRGGC are as follows:

  1. To study the current diagnosis and treatment of gallbladder cancer in China.
  2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.
  3. To improve the accurate staging of gallbladder cancer.
  4. To standardize the treatment with gallbladder cancer.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • China
    • Anhui
      • Bengbu, Anhui, China, 233004
        • Recruiting
        • The First Affiliated Hospital of Bengbu Medical College
        • Contact:
          • Jianguang Jia, MD
      • Hefei, Anhui, China, 230022
        • Recruiting
        • The First Affiliated Hospital of Anhui Medical University
        • Contact:
          • Yeben Qian, MD
      • Hefei, Anhui, China, 230001
        • Recruiting
        • Anhui Provincial Hospital
        • Contact:
          • Lianxin Liu, MD
    • Heilongjiang
      • Harbin, Heilongjiang, China, 150081
        • Recruiting
        • Harbin Medical University Cancer Hospital
        • Contact:
          • Bing Li, 150081
      • Harbin, Heilongjiang, China, 150086
        • Recruiting
        • The Second Affiliated Hospital of Harbin Medical University
        • Contact:
          • Yunfu Cui, MD
      • Harbin, Heilongjiang, China, 150009
        • Recruiting
        • The First Affiliated Hospital of Harbin Medical University
        • Contact:
          • Bei Sun, MD
    • Henan
      • Zhengzhou, Henan, China, 450052
        • Recruiting
        • The Fifth Affiliated Hospital of Zhengzhou University
        • Contact:
          • Xiaoyong Li, MD
      • Zhengzhou, Henan, China, 450003
        • Recruiting
        • Henan Cancer Hospital
        • Contact:
          • Yawei Hua, MD
    • Hunan
      • Changsha, Hunan, China, 410001
        • Recruiting
        • People's Hospital of Hunan Province
        • Contact:
          • Changjun Liu, MD
    • Inner Mongolia
      • Baotou, Inner Mongolia, China, 014040
        • Recruiting
        • Baotou City Central Hospital
        • Contact:
          • Mingzhang Li, MD
    • Jiangsu
      • Changshu, Jiangsu, China, 215500
        • Recruiting
        • Changshu No.1 People's Hospital
        • Contact:
          • Jianfeng Gu, MD
      • Changzhou, Jiangsu, China, 213003
        • Recruiting
        • Changzhou No.2 People's Hospital
        • Contact:
          • Chunfu Zhu, MD
      • Nanjing, Jiangsu, China, 210008
        • Recruiting
        • Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
        • Contact:
          • Yudong Qiu, MD
      • Nantong, Jiangsu, China, 226001
        • Recruiting
        • The First People's Hospital of Nantong
        • Contact:
          • Hong Zang, MD
      • Nantong, Jiangsu, China, 226021
        • Recruiting
        • Affiliated Hospital of Nantong University
        • Contact:
          • Peng Wang, MD
      • Nantong, Jiangsu, China, 226361
        • Recruiting
        • Nantong Tumor Hospital
        • Contact:
          • Hongyu Cai, MD
      • Suzhou, Jiangsu, China, 215004
        • Recruiting
        • The Second Affiliated Hospital of Suzhou University
        • Contact:
          • Xiaoming Ma, MD
      • Taicang, Jiangsu, China, 215400
        • Recruiting
        • The First People's Hospital of Taicang
        • Contact:
          • Yi Wang, MD
      • Wuxi, Jiangsu, China, 214002
        • Recruiting
        • Wuxi Second People's Hospital
        • Contact:
          • Lei Wang, MD
      • Xuzhou, Jiangsu, China, 221006
        • Recruiting
        • The Affiliated Hospital of Xuzhou Medical University
        • Contact:
          • Jian Hong, MD
      • Xuzhou, Jiangsu, China, 221009
        • Recruiting
        • Xuzhou Central Hospital
        • Contact:
          • Yuzhen Xu, MD
    • Jiangxi
      • Nanchang, Jiangxi, China, 330006
        • Recruiting
        • Jiangxi Provincial People's Hospital
        • Contact:
          • Xiaoliang Chen, MD
      • Nanchang, Jiangxi, China, 330008
        • Recruiting
        • The Second Affiliated Hospital of Nanchang University
        • Contact:
          • Lu Fang, MD
      • Nanchang, Jiangxi, China, 330019
        • Recruiting
        • The First Affiliated Hospital of Nanchang University
        • Contact:
          • Linhui Zheng, MD
    • Jilin
      • Changchun, Jilin, China, 130021
        • Recruiting
        • The First Bethune Hospital of Jilin University
        • Contact:
          • Yajun Geng, MD
      • Changchun, Jilin, China, 130041
        • Recruiting
        • the Second Hospital of Jilin University
        • Contact:
          • Xuewen Zhang, MD
      • Changchun, Jilin, China, 130033
        • Recruiting
        • China-Japan Union Hospital of Jilin University
        • Contact:
          • Hong Cao, MD
    • Lanzhou
      • Gansu, Lanzhou, China, 730000
        • Recruiting
        • The First Hospital of Lanzhou University
        • Contact:
          • Xun Li, MD
    • Liaoning
      • Shenyang, Liaoning, China, 110004
        • Recruiting
        • Shengjing Hospital of China Medical University
        • Contact:
          • Chaoliu Dai, MD
    • Qinghai
      • Xining, Qinghai, China, 810007
        • Recruiting
        • Qinghai Provincial People's Hospital
        • Contact:
          • Haihong Zhu, MD
    • Shaanxi
      • Xi'an, Shaanxi, China, 710061
        • Recruiting
        • The First Affiliated Hospital of Xi'an Jiaotong University
        • Contact:
          • Chang Liu, MD
    • Shanghai
      • Shanghai, Shanghai, China, 200092
        • Recruiting
        • Xinhua Hospital
      • Shanghai, Shanghai, China, 200032
        • Recruiting
        • Zhongshan Hospital
      • Shanghai, Shanghai, China, 200080
        • Recruiting
        • Shanghai General Hospital
        • Contact:
          • Junmin Xu, MD
      • Shanghai, Shanghai, China, 200438
        • Recruiting
        • Eastern Hepatobiliary Surgery Hospital
        • Contact:
          • Xiaoqing Jiang
      • Shanghai, Shanghai, China, 200062
        • Recruiting
        • Putuo District People's Hospital of Shanghai
        • Contact:
          • Jiahua Yang, MD
      • Shanghai, Shanghai, China, 201100
        • Recruiting
        • Central Hospital of Minhang District
        • Contact:
          • Longhua Rao, MD
      • Shanghai, Shanghai, China, 201399
        • Recruiting
        • Shanghai Pudong Hospital
        • Contact:
          • Xiaoping Yang, MD
      • Shanghai, Shanghai, China, 201499
        • Recruiting
        • Shanghai Fengxian District Central Hospital
        • Contact:
          • Xueli Zhang, MD
      • Shanghai, Shanghai, China, 202150
        • Recruiting
        • Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
        • Contact:
          • Zhewei Fei, MD
    • Shanxi
      • Changzhi, Shanxi, China, 046000
        • Recruiting
        • Heping Hospital Affiliated to Changzhi Medical College
        • Contact:
          • Buqiang Wu, MD
      • Taiyuan, Shanxi, China, 030001
        • Recruiting
        • First Hospital of Shanxi Medical University
        • Contact:
          • Jiansheng Liu, MD
      • Taiyuan, Shanxi, China, 030013
        • Recruiting
        • Shanxi Provincial Cancer Hospital
        • Contact:
          • Xueyi Dang, MD
    • Tianjin
      • Tianjin, Tianjin, China, 300060
        • Recruiting
        • Tianjin Medical University Cancer Hospital
        • Contact:
          • Jihui Hao, MD
    • Xinjiang
      • Ürümqi, Xinjiang, China, 830054
        • Recruiting
        • The First Affiliated Hospital of Xinjiang Medical University
        • Contact:
          • Wei Han, MD
    • Yunnan
      • Kunming, Yunnan, China, 650031
        • Recruiting
        • The First Affiliated Hospital of Kunming Medical University
        • Contact:
          • Kunhua Wang, MD
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310022
        • Recruiting
        • Zhejiang Cancer Hospital
      • Hangzhou, Zhejiang, China, 310009
        • Recruiting
        • the Second Affiliated Hospital of Zhejiang University School of Medicine
        • Contact:
          • Jinhui Zhu, MD
      • Hangzhou, Zhejiang, China, 310020
        • Recruiting
        • Sir Run Run Shaw Hospital
        • Contact:
          • Defei Hong, MD
      • Huzhou, Zhejiang, China, 313000
        • Recruiting
        • Huzhou Central Hospital
        • Contact:
          • Weilong Cai, MD
      • Ningbo, Zhejiang, China, 315010
        • Recruiting
        • Ningbo First Hospital
        • Contact:
          • Zhiping Zhang, MD
      • Ningbo, Zhejiang, China, 315040
        • Recruiting
        • Yinzhou Hospital Affiliated to Medical School of Ningbo University
        • Contact:
          • Kejun Hua, MD
      • Shaoxing, Zhejiang, China, 312000
        • Recruiting
        • Shaoxing People's Hospital
        • Contact:
          • Feng Tao, MD
      • Shaoxing, Zhejiang, China, 312000
        • Recruiting
        • Shaoxing Second Hospital
        • Contact:
          • Zaiyang Zhang, MD
      • Wenzhou, Zhejiang, China, 325015
        • Recruiting
        • The First Affiliated Hospital of Wenzhou Medical University
        • Contact:
          • Mengtao Zhou, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients from 2008 to 2020 diagnosed with gallbladder cancer in collaborated hospitals in China.

Description

Inclusion Criteria:

  • Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).
  • Patients with accessible electronic medical record

Exclusion Criteria:

  • Patients with undetermined primary site of cancer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Overall Survival
Time Frame: 5 years
The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up.
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Shanghai Jiao Tong University School of Medicine

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Tianjin Medical University Cancer Hospital
Zhejiang Cancer Hospital
Xijing Hospital
The First Affiliated Hospital of Anhui Medical University
The First Affiliated Hospital of Nanchang University
LanZhou University
Shanghai Zhongshan Hospital
Henan Cancer Hospital
Qilu Hospital of Shandong University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shengjing Hospital
First Affiliated Hospital Xi'an Jiaotong University
The Affiliated Hospital of Qingdao University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Shandong Provincial Hospital
The First Affiliated Hospital of Zhengzhou University
Jiangxi Provincial Cancer Hospital
Shanxi Provincial Cancer Hospital
The First Hospital of Jilin University
Eastern Hepatobiliary Surgery Hospital
Xuzhou Central Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital of Kunming Medical College
Sir Run Run Shaw Hospital
First Affiliated Hospital of Wenzhou Medical University
Shaoxing People's Hospital
The Second Affiliated Hospital of Harbin Medical University
Qinghai People's Hospital
The First Affiliated Hospital of Shanxi Medical University
Shaoxing Second Hospital
First Affiliated Hospital of Xinjiang Medical University
Ningbo No. 1 Hospital
Huizhou Municipal Central Hospital
First Affiliated Hospital Bengbu Medical College
Second Affiliated Hospital of Nanchang University
Harbin Medical University
Changzhi Medical College
Second Hospital of Jilin University
The Affiliated Hospital of Xuzhou Medical University
China-Japan Union Hospital, Jilin University
First Affiliated Hospital of Harbin Medical University
Anhui Provincial Hospital
Shanghai Pudong Hospital
Second Affiliated Hospital of Suzhou University
The First People's Hospital of Changzhou
Hainan People's Hospital
Affiliated Hospital of Nantong University
Jiangxi Provincial People's Hopital
Changzhou No.2 People's Hospital
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
The First People's Hospital of Taicang
Wuxi Second People's Hospital
The First People's Hospital of Nantong
Baotou Central Hospital
Shanghai Fengxian District Central Hospital
Central Hospital of Minhang District, Shanghai
Putuo District People's Hospital of Shanghai
Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Yinzhou Hospital Affiliated to Medical School of Ningbo University
People's Hospital of Hunan Province
Taizhou Municipal Hospital
Xinghua City People's Hospital
Tongliao City Hospital

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Yingbin Liu, MD, PhD, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2008

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2022

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 24, 2019

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 24, 2019

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 28, 2019

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 30, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 29, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • CRGGC_LYB_2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

No plan for IPD access is scheduled.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings